View in Other Languages

Regeneus Ltd

ASX:RGS ISIN:AU000000RGS6

Regeneus Ltd ASX:RGSRegeneus Ltd (ASX:RGS) is a Sydney-based clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies to address significant unmet medical needs in the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, neuropathic pain and dermatology.

       

News

Regeneus Ltd (ASX:RGS) Quarterly Report

🕔10/31/2019 1:38:20 PM 720

Regeneus Ltd (ASX:RGS) (Regeneus or the Company), a clinical-stage regenerative medicine company, today released its quarterly cashflow report for the period ending 30 September 2019 (Q1 FY20).

Read Full Article

Regeneus Ltd (ASX:RGS) Annual Report 2019

🕔10/30/2019 8:15:27 AM 812

Regeneus Ltd (ASX:RGS) is a Sydney Sydney-based clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell cell-based therapies to address significant unmet medical needs in the human health markets.

Read Full Article

Regeneus Ltd (ASX:RGS) Receives A$1.5 million in R&D Tax Incentives

🕔10/15/2019 11:08:59 AM 959

Regeneus Ltd (ASX:RGS) (Regeneus or the Company), a clinical-stage regenerative medicine company, has received $1.5 million in R&D Tax Incentives from the Australian Tax Office for FY19.

Read Full Article

Regeneus Ltd (ASX:RGS) Financial Report - Year Ended 30 June 2019

🕔9/26/2019 9:32:37 AM 1493

Regeneus Ltd (ASX:RGS) (Regeneus or the Company), a clinical-stage regenerative medicine company, releases its financial results for the financial year ended 30 June 2019 (FY2019).

Read Full Article

Regeneus Ltd (ASX:RGS) Appoints International Directors for Global Growth

🕔4/29/2019 8:48:54 AM 2328

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce the appointment of John Chiplin, PhD and Alan W. Dunton, M.D. to its Board of Directors, effective 29 April 2019 as independent, Non-Executive Directors.

Read Full Article

Regeneus Ltd (ASX:RGS) Quarterly Results

🕔4/11/2019 10:48:52 AM 2501

Regeneus Ltd (ASX:RGS) provides the Company's Quarterly results for the period ended 31 March, 2019.

Read Full Article

Regeneus Ltd (ASX:RGS) Half-Year Report

🕔3/1/2019 8:08:49 AM 3032

Regeneus (ASX:RGS) is an ASX-listed clinical-stage regenerative medicine company developing a portfolio of novel cell-based therapies targeting significant unmet medical needs in human and animal health, with an initial focus on osteoarthritis, neuropathic pain and dermatology. The Company's product pipeline is underpinned by proprietary stem cell technologies.

Read Full Article

Regeneus Ltd (ASX:RGS) Directors Provide $2.5M Loan to Extend Funding Runway

🕔2/28/2019 1:27:23 PM 2977

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce that its Board of Directors have put in place loan funding of $2.5m to extend the Company's funding runway for the development and licensing of its clinical assets.

Read Full Article

Regeneus Ltd (ASX:RGS) Quarterly Report

🕔1/30/2019 3:51:34 PM 2970

Regeneus Ltd (ASX:RGS) provides the Company's Quarterly results for the period ended 31 December 2018.

Read Full Article

Regeneus Ltd (ASX:RGS) New CEO Appointed to Accelerate Global Growth

🕔1/23/2019 9:48:46 AM 3605

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce that it has appointed Leo Lee as the company's new Chief Executive Officer and member of Board of Directors, effective immediately. Leo will succeed the outgoing CEO, John Martin, after 10 years of valuable service to the company.

Read Full Article
###

124,378 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 237) (Last 30 Days: 1215) (Since Published: 57038) 

Company Data

    Headquarters
  • 2 Paddington Street
    Paddington NSW 2021
    Australia
  • Telephone
  • +61-2-9499-8010 
  • Fax
  • +61-2-9499-8020 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.regeneus.com.au
  • E:
  • info@regeneus.com.au

Company Reports